Charles van der Horst

Author PubWeight™ 76.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004 7.67
2 Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet 2010 5.41
3 Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003 4.57
4 Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002 2.83
5 Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet 2012 2.69
6 Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2011 2.38
7 Microalbuminuria in HIV infection. AIDS 2007 2.28
8 Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa. AIDS 2010 2.13
9 Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis 2013 2.02
10 Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis 2012 1.56
11 Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials 2006 1.45
12 Low absolute neutrophil counts in african infants. J Int Assoc Physicians AIDS Care (Chic) 2005 1.44
13 Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemp Clin Trials 2007 1.39
14 Differences between international recommendations on breastfeeding in the presence of HIV and the attitudes and counselling messages of health workers in Lilongwe, Malawi. Int Breastfeed J 2006 1.32
15 Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant 2011 1.28
16 Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults. AIDS 2007 1.26
17 Health outcomes of HIV-exposed uninfected African infants. AIDS 2013 1.21
18 Superior uptake and outcomes of early infant diagnosis of HIV services at an immunization clinic versus an "under-five" general pediatric clinic in Malawi. J Acquir Immune Defic Syndr 2012 1.20
19 Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr 2005 1.19
20 A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis. AIDS 2012 1.19
21 A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr 2012 1.18
22 Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi. J Nutr 2005 1.16
23 Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr 2010 1.15
24 A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS 2004 1.14
25 Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One 2011 1.14
26 Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev 2009 1.07
27 Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol 2012 1.02
28 Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study. J Infect Dis 2013 0.98
29 Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study. Contemp Clin Trials 2011 0.96
30 Using formative research to develop a context-specific approach to informed consent for clinical trials. J Empir Res Hum Res Ethics 2006 0.94
31 Variability in drug metabolizing enzyme activity in HIV-infected patients. Eur J Clin Pharmacol 2010 0.91
32 Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants. Pediatr Infect Dis J 2012 0.90
33 Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A. Virology 2012 0.90
34 Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay. J Clin Virol 2010 0.90
35 Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods. AIDS Behav 2012 0.88
36 Exploring the feasibility of engaging Traditional Birth Attendants in a prevention of mother to child HIV transmission program in Lilongwe, Malawi. Malawi Med J 2012 0.86
37 Evaluating the benefits of incorporating traditional birth attendants in HIV prevention of mother to child transmission service delivery in Lilongwe, Malawi. Afr J Reprod Health 2014 0.85
38 Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study. J Infect Dis 2013 0.85
39 Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy. AIDS 2003 0.85
40 Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study. Antivir Ther 2014 0.84
41 Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi. Malawi Med J 2012 0.84
42 New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep 2012 0.84
43 HIV and tuberculosis in Russia and eastern Europe: sounding the alarm. AIDS 2009 0.82
44 A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. Contemp Clin Trials 2006 0.81
45 Patterns of body composition among HIV-infected, pregnant Malawians and the effects of famine season. Matern Child Health J 2013 0.81
46 Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study. J Acquir Immune Defic Syndr 2016 0.79
47 Maternal mid-upper arm circumference is associated with birth weight among HIV-infected Malawians. Nutr Clin Pract 2012 0.78
48 HIV/hepatitis C virus co-infection: basic, behavioral and clinical research in mental health and drug abuse. AIDS 2005 0.78
49 Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission. AIDS 2014 0.77
50 Definition of proteinuria among women with HIV infection. Kidney Int 2004 0.75
51 Time of HIV diagnosis in infants after weaning from breast milk. AIDS 2015 0.75
52 The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit. PLoS One 2013 0.75
53 Tuberculosis and HIV: danse macabre. AIDS 2010 0.75
54 Role of antibiotics in reducing childhood mortality in resource-poor settings. AIDS 2016 0.75
55 Research as a path to wide-scale implementation of antiretroviral therapy in Africa. J HIV Ther 2004 0.75
56 HIV Infected Children in Malawi have Decreased Performance on the 6 Minute Walk Test with Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status. Pediatr Infect Dis J 2017 0.75